The FDA NDI (New Dietary Ingredient) Notification Process for Gummies
The FDA NDI (New Dietary Ingredient) Notification Process for Gummies
In the United States, the supplement industry often operates under the assumption that if an ingredient is natural, it is legal to sell. This is a profound and legally dangerous misunderstanding of the Dietary Supplement Health and Education Act (DSHEA) of 1994.
The FDA does not pre-approve dietary supplements, but it does heavily regulate the ingredients that go into them. The line dividing a legal supplement from an "adulterated" (illegal) product is the New Dietary Ingredient (NDI) Notification.
If a brand formulates a gummy using an exotic botanical extract or a newly synthesized compound that was not sold in the US before October 15, 1994, and fails to submit an NDI notification, the FDA can seize the product, issue warning letters, and shut down the business. Here is the technical breakdown of the NDI process and how to protect your brand from FDA enforcement.
1. The Pre-1994 "Grandfather" Clause
The foundation of DSHEA is the timeline. If an ingredient was marketed as a dietary supplement in the United States prior to October 15, 1994, it is considered an "Old Dietary Ingredient" (ODI). ODIs are "grandfathered" into the system and generally do not require a formal FDA notification before use.
- Examples of ODIs: Vitamin C, Calcium, standard Echinacea root powder, generic Fish Oil.
The Innovation Trap
The supplement industry thrives on innovation. Brands are constantly searching for new, patented extracts with higher bioavailability or exotic botanicals from Asia or South America. If an ingredient was NOT marketed in the US before October 15, 1994, it is a New Dietary Ingredient (NDI).
By law, you must notify the FDA at least 75 days before introducing an NDI into interstate commerce.
2. The Extraction Method Changes Everything
This is where the majority of brands accidentally violate federal law. They assume that because a plant is an "Old Dietary Ingredient," any extract of that plant is also legal. The FDA disagrees.
If you change the traditional manufacturing or extraction process of a grandfathered ingredient, the FDA often classifies the resulting extract as a New Dietary Ingredient.
The CO2 and Solvent Example
Let's look at Turmeric. Standard, crude turmeric powder has been sold for over a century; it is an ODI. However, if a raw material supplier uses a novel, highly advanced Supercritical CO2 extraction process to isolate 95% pure curcuminoids, the FDA views this resulting extract as chemically altered from its traditional food form. It is now an NDI. If you put that novel extract into your gummy without an NDI notification, your gummy is legally adulterated.
3. The NDI Notification Dossier
Filing an NDI notification is not simply filling out a one-page form. It is a grueling, highly technical scientific submission.
The brand (or the raw material manufacturer) must provide the FDA with a comprehensive dossier proving that the new ingredient is reasonably expected to be safe under the specific conditions of use recommended on your label.
The dossier must include:
- Chemistry and Identity: Exact molecular structure, botanical taxonomy, and the complete manufacturing flow chart.
- Toxicology Data: Animal studies, mutagenicity tests (AMES test), and sub-chronic toxicity studies (usually 90-day rat studies) to prove the ingredient does not cause organ damage.
- History of Safe Use: Epidemiological data proving the ingredient has been safely consumed by humans in other parts of the world.
The High Failure Rate
The FDA rejects (or "objects to") a massive percentage of NDI notifications. Often, the FDA objects because the toxicology data is insufficient, or because the brand failed to explicitly describe the target demographic (e.g., failing to exclude pregnant women if safety data for that group is missing).
If the FDA objects, you cannot legally sell the gummy.
Explore Export-Ready Manufacturing
4. The Supply Chain Solution: Master Files and Piggybacking
Filing an NDI notification can cost between $100,000 and $500,000 in toxicological testing and legal fees. A D2C gummy brand cannot afford this.
The Strategy
You must push this regulatory burden up the supply chain. When formulating a gummy with a novel, high-tech active ingredient, your contract manufacturer must source that ingredient from a premium raw material supplier who has already successfully submitted an NDI notification to the FDA.
- The Master File: The ingredient supplier holds the NDI Master File.
- Piggybacking: As a brand, you purchase this specific, NDI-cleared ingredient. You are then legally protected under the supplier's FDA notification (provided you do not exceed the daily dosage limits established in their original safety dossier).
Warning: You cannot buy a cheap, generic knock-off of an ingredient and claim it is covered by the premium supplier's NDI. The FDA strictly enforces that the NDI clearance applies only to the specific extract manufactured by the submitting company.
View Commercial Strategy Services
FAQ
Does the FDA approve NDI notifications? No. The FDA does not "approve" supplements. If you submit an NDI and the FDA does not issue an objection letter within 75 days, they simply "acknowledge" receipt without objection. This allows you to legally go to market, but the FDA still retains the right to pull the product later if safety issues arise.
What is GRAS, and is it an alternative to an NDI? GRAS stands for "Generally Recognized as Safe." If an ingredient has been formally determined to be GRAS by a panel of qualified toxicologists for use in conventional food, it is exempt from the NDI notification requirement. Many novel gummy ingredients (like certain soluble fibers or new natural sweeteners) rely on GRAS status rather than an NDI.
How do I know if an ingredient is an NDI or an ODI? There is no definitive, FDA-published list of ODIs. You must work with an experienced regulatory consultant who can search industry databases and historical catalogs to prove the ingredient was sold in the US prior to 1994.
Formulate for Total Compliance
In the supplement industry, ignorance of the law is not a defense; it is a liability. Formulating a gummy with cutting-edge, highly effective ingredients requires absolute certainty that those ingredients are legally permitted in the US market.
At Probiota Innovations, we build our formulations on a foundation of unshakeable regulatory compliance. We source premium active ingredients exclusively from global suppliers who possess pristine NDI and GRAS documentation. We ensure that your innovative, high-efficacy gummy line is completely insulated from FDA enforcement and ready for aggressive, legal scaling.
Request a Project Brief Explore Functional Gummy Manufacturing
Want to discuss your formulation?
Our experts help brands launch technically complex probiotic and functional gummies.
